Bernadette Connaughton

Ms. Connaughton brings more than 30 years of global strategic, commercial, and biopharmaceutical industry expertise to the Board of Directors.  Ms. Connaughton retired from Bristol-Myers Squibb Pharmaceutical Company, a multinational pharmaceutical company, where she served in senior management positions from 2004 to October 2017.  She most recently served as Bristol-Myers Squibb’s President, Intercontinental Region.  Ms. Connaughton was recently a member of the board of directors of Visterra, Inc., a private clinical-stage biotechnology company, acquired by Otsuka. She also previously served on the European Federation of Pharmaceutical Industry Association, Patient Access, and European Markets Committees. Ms. Connaughton currently serves on the board of directors of Editas Medicine, Syneos Health, Inc., and Zealand Pharma A/S. Ms. Connaughton received her BA from Johns Hopkins University and her MBA from The Wharton School, University of Pennsylvania. Ms. Connaughton is the Chair of the Compensation Committee.